Skip to content

Effect of Eugenia caryophylata extract on primary knee osteoarthritis

Effect of topical application of Eugenia caryophylata extract compared with diclofenac and placebo on primary knee osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201501056480N8
Enrollment
120
Registered
2015-01-27
Start date
2015-01-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary knee osteoarthritis. Primary generalized (osteo)arthrosis

Interventions

Intervention 1: Intervention group received the amount of 1 mg of Clove extract ointment 10%3 times daily. Intervention 2: Intervention Group received 1 mg of topical diclofenac 1% 3 times daily . Int
Treatment - Drugs
Placebo
Intervention group received the amount of 1 mg of Clove extract ointment 10%3 times daily.
Intervention Group received 1 mg of topical diclofenac 1% 3 times daily .
Control group received1 mg of placepo ointment 3 times daily.

Sponsors

Vice chancellery for Research and Technology,Shahrekord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : having 30 years old , maximum 60 years, knee osteoarthritis proven by clinical symptoms, examination and diagnosis criteria of this disease, which despite the usual care is not relieved for 3 months. Exclusion criteria: presence of severe concomitant diseases such as metabolic and gastrointestinal diseases, fluctuating doses of drugs during the study, severe infection, allergy to clove extract, pregnancy, lactation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
General pain. Timepoint: baseline, one week, three weeks and four weeks after treatment. Method of measurement: questionnaire (WOMAC).;Stiffness. Timepoint: baseline, one week, three weeks and four weeks after treatment. Method of measurement: questionnaire (WOMAC).;Physical activity. Timepoint: baseline, one week, three weeks and four weeks after treatment. Method of measurement: questionnaire (WOMAC).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Morteza Dehghan

Shahrekord University of Medical Sciences

dehghan_mortaza@yahoo.com+98 38 3334 2414

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026